<PAGE>
Exhibit 2
AMENDED
STOCK PURCHASE AGREEMENT
AND
PLAN OF REORGANIZATION
among
Ocean West Enterprises, Inc.,
dba Ocean West Funding,
Monogenesis Corporation
and
Shareholders of Ocean West Enterprises, Inc.
Dated: ___________, 2000
<PAGE>
AMENDED
STOCK PURCHASE AGREEMENT
AND
PLAN OF REORGANIZATION
Table of Contents
<TABLE>
<S> <C>
ARTICLE I
SECURITIES
1.1 Exchange of Securities......................................................... 2
----------------------
1.2 Monogenesis Warrants........................................................... 2
--------------------
1.3 Issuance of Securities to Monogenesis.......................................... 2
-------------------------------------
1.4 Registration Statement......................................................... 3
----------------------
1.5 Dispositions of Shares By the Shareholders..................................... 3
------------------------------------------
ARTICLE II
CLOSING
2.1 Time and Place................................................................. 3
--------------
2.2 Actions at the Closing......................................................... 3
----------------------
2.3 Holding Company Directors...................................................... 3
-------------------------
2.4 Simultaneous Actions........................................................... 4
--------------------
ARTICLE III
REPRESENTATIONS AND WARRANTS OF OWE
3.1 Organization................................................................... 4
------------
3.2 Capitalization................................................................. 4
--------------
3.3 Subsidiaries................................................................... 4
------------
3.4 Authority...................................................................... 4
---------
3.5 Financial Statements........................................................... 5
--------------------
3.6 Absence of Undisclosed Liabilities............................................. 5
----------------------------------
3.7 Absence of Changes............................................................. 5
------------------
3.8 Title to Assets................................................................ 6
---------------
3.9 Litigation..................................................................... 6
----------
3.10 Compliance; Governmental Authorization......................................... 6
--------------------------------------
3.11 Labor Relations; Employees..................................................... 7
--------------------------
3.12 Employee Benefit Plans......................................................... 7
----------------------
3.13 Intellectual Property.......................................................... 7
---------------------
3.14 Accounts and Notes Receivable.................................................. 7
-----------------------------
3.15 Loan Inventories............................................................... 8
----------------
3.16 Tax Matters.................................................................... 8
-----------
3.17 Books and Records.............................................................. 8
-----------------
3.18 Disclosure..................................................................... 8
----------
</TABLE>
i
<PAGE>
<TABLE>
<S> <C>
3.19 Best Knowledge of OWE.......................................................... 8
---------------------
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF THE SHAREHOLDERS
4.1 Authority...................................................................... 9
---------
4.2 Stock Ownership................................................................ 9
---------------
4.3 Investment Representations..................................................... 9
--------------------------
ARTICLE V
REPRESENTATIONS AND WARRANTIES OF MONOGENESIS
5.1 Organization................................................................... 10
------------
5.2 Authority...................................................................... 10
---------
5.3 Shareholders................................................................... 11
------------
ARTICLE VI
COVENANTS OF OWE
6.1 Conduct of Business Until Closing Date......................................... 11
--------------------------------------
6.2 Access to Properties and Records............................................... 11
--------------------------------
6.3 Advice of Changes.............................................................. 11
-----------------
6.4 Conduct........................................................................ 12
-------
6.5 Approvals, Consents............................................................ 12
-------------------
ARTICLE VII
COVENANTS OF MONOGENESIS
7.1 Confidentiality; Return of Documents........................................... 12
------------------------------------
ARTICLE VIII
CONDITIONS TO OBLIGATIONS OF MONOGENESIS
8.1 Accuracy of Representations and Warranties..................................... 12
------------------------------------------
8.2 Performance of Agreements...................................................... 12
-------------------------
8.3 Officer's Certificate.......................................................... 13
---------------------
8.4 Secretary's Certificate........................................................ 13
-----------------------
8.5 Consents, Authorizations....................................................... 13
------------------------
8.6 Legislation.................................................................... 13
-----------
8.7 Monogenesis Warrants........................................................... 13
--------------------
8.8 Issuance, Registration and Distribution of Shares and Warrants................. 13
--------------------------------------------------------------
8.9 Good Standing Certificates..................................................... 13
--------------------------
8.10 Financial Statements........................................................... 13
---------------------
8.11 Casualty....................................................................... 14
--------
ARTICLE IX
CONDITIONS TO OBLIGATIONS OF OWE AND THE SHAREHOLDERS
9.1 Accuracy of Representations and Warranties....................................... 14
------------------------------------------
</TABLE>
ii
<PAGE>
<TABLE>
<S> <C>
9.2 Performance of Agreements........................................................ 14
-------------------------
9.3 Officer's Certificate............................................................ 14
---------------------
9.4 Secretary's Certificate.......................................................... 14
-----------------------
9.5 Consents, Authorizations......................................................... 14
------------------------
9.6 Legislation...................................................................... 15
-----------
9.7 Monogenesis Warrants............................................................. 15
--------------------
9.8 Issuance, Registration and Distribution of Shares and Warrants................... 15
--------------------------------------------------------------
ARTICLE X
TERMINATION
10.1 Termination.................................................................... 15
-----------
ARTICLE XI
INDEMNIFICATION
11.1 Indemnification................................................................ 16
---------------
11.2 Third Party Claims............................................................. 17
------------------
11.3 Remedies Cumulative............................................................ 17
-------------------
11.4 Recoveries..................................................................... 17
----------
ARTICLE XII
MISCELLANEOUS
12.1 Expenses; Transfer Taxes....................................................... 17
------------------------
12.2 Binding Effect................................................................. 17
--------------
12.3 Entire Agreement; Amendments................................................... 18
----------------------------
12.4 Headings....................................................................... 18
--------
12.5 Notices........................................................................ 18
-------
12.6 Publicity...................................................................... 19
---------
12.7 Governing Law.................................................................. 19
-------------
12.8 Waivers........................................................................ 19
-------
12.9 Defined Terms.................................................................. 19
-------------
12.10 Fees........................................................................... 19
----
12.11 Counterparts................................................................... 19
------------
SCHEDULE 1.1
Holding Company Stock To Be Issued to the
-----------------------------------------
Shareholders and Pursuant to the Monogenesis Warrants...................... 21
-----------------------------------------------------
SCHEDULE 3.1
Jurisdictions in Which OWE is Qualified to Do Business................................ 22
------------------------------------------------------
Officers and Directors of OWE......................................................... 22
-----------------------------
SCHEDULE 3.2
Shareholders of Ocean West Enterprises, Inc........................................... 22
-------------------------------------------
</TABLE>
iii
<PAGE>
<TABLE>
<S> <C>
Convertible Securities, Options,
-------------------------------
Warrants, Agreements Relating to Stock of OWE.................................. 23
---------------------------------------------
SCHEDULE 3.12
Employee Benefit Plans................................................................ 23
----------------------
SCHEDULE 3.13
Intellectual Property................................................................. 23
---------------------
EXHIBIT 1.3
Form of Common Stock Purchase Warrants................................................ 24
--------------------------------------
EXHIBIT 3.5
Certificate Relating to Financial Statements.......................................... 24
--------------------------------------------
</TABLE>
iv
<PAGE>
AMENDED
STOCK PURCHASE AGREEMENT
AND
PLAN OF REORGANIZATION
----------------------
This Amended Stock Purchase Agreement and Plan of Reorganization (the
"Agreement") is entered into as of this ____ day of ________, 2000 by and among
Ocean West Enterprises, Inc., dba Ocean West Funding, a California corporation
("OWE"); Monogenesis Corporation, a Delaware corporation ("Monogenesis"); and
the holders of the voting common stock of OWE listed on Schedule 3.2, attached
------------
hereto and made a part hereof (collectively, the "Common Shareholders"). The
holders of preferred stock of OWE (collectively, the "Preferred Shareholders")
listed on Schedule 3.2 will evidence their acceptance of the terms of this
------------
Agreement by exchanging their preferred stock of OWE for Common Shares or
Preferred Shares of the holding company to be created as provided herein. The
Common Shareholders and the Preferred Shareholders are collectively referred to
as the "Shareholders."
WHEREAS, Monogenesis is a closed-end investment company with in excess of
1,000 shareholders which was formed to provide a mechanism for companies to
become reporting companies under the Securities Act of 1934 through
distributions to its shareholders;
WHEREAS, OWE desires to form a holding company which will have a class of
shares which may be traded publicly to facilitate access to equity capital and
future acquisitions and to provide liquidity for its shareholders and value to
employee stock incentive programs;
WHEREAS, a Delaware corporation (the "Holding Company") has been created
which will acquire all of the issued and outstanding shares of stock of OWE in a
stock for stock exchange;
WHEREAS, the Holding Company will have four classes of stock authorized:
Common Shares, Class B Common Shares, Class D Common Shares and Preferred Shares
as well as the common stock purchase warrants described below;
WHEREAS, as of September 30, 2000, OWE had authorized 100,000 shares of
Common Stock, 30,000 of which were issued and outstanding, and 50,000 shares of
Preferred Stock, of which 1,000 shares of Series C, 1,500 shares of Series D,
1,200 shares of Series E, 1,250 of Series F, 2,000 of Series G, 550 of Series I,
1,000 of Series K and 183 of Series L were issued and outstanding;
WHEREAS, OWE has outstanding warrants to purchase 600 shares of common
stock of OWE;
WHEREAS, the Common Shareholders own all of the issued and outstanding
common stock of OWE and desire to exchange their stock in OWE for stock in the
Holding Company, in the ratio of 8 Class B Common Shares and 140 Common Shares
of the Holding Company for each share of common stock of OWE;
WHEREAS, the Preferred Shareholders own all of the issued and outstanding
preferred stock of OWE and desire to exchange such preferred stock for 1,537,200
Common Shares, 1,000 Preferred Shares -Series C, 680 Preferred Shares - Series
E, 1,050 Preferred Shares - Series F, 2,000 Preferred Shares - Series G, 125
Preferred Shares - Series I, and 74 Preferred Shares - Series L;
<PAGE>
WHEREAS, Monogenesis has received warrants to purchase 600 shares of common
stock of OWE for which it will receive warrants to purchase 88,800 Common Shares
of the Holding Company;
WHEREAS, the Holding Company will authorize Common Stock Purchase Warrants
(the "Warrants") to purchase Common Shares of the Holding Company (which
Warrants will be exercisable for 10 months and have an exercise price of $2.00
per share);
WHEREAS, prior to the Closing Date (as hereinafter defined), Monogenesis
will purchase, and the Holding Company will issue to Monogenesis, 300,000 of its
Common Shares at a purchase price of $0.01 per share together with 3,000,000
Warrants at a purchase price of $0.001 per Warrant;
WHEREAS, prior to the stock for stock exchange, the Holding Company (and
OWE) will file a registration statement (the "Registration Statement")
registering 2,045,842 of the Common Shares to be issued to the Shareholders, all
of the Common Shares which may be issued to Monogenesis upon the exercise of its
warrants (including Common Shares received upon conversion of Class B Common
Shares), all of the Common Shares and all of the Warrants to be issued to
Monogenesis and all of the Common Shares underlying the Warrants pursuant to the
Securities Act of 1933, as amended (the "1933 Act"); and
WHEREAS, on the Closing Date, Monogenesis will authorize its transfer agent
to distribute to Monogenesis shareholders 100 Common Shares of the Holding
Company and 1,100 Warrants of the Holding Company for each share of stock of
Monogenesis held;
NOW THEREFORE, in consideration of the mutual covenants and conditions
hereinafter set forth, the parties agree as follows:
ARTICLE I
SECURITIES
1.1 Exchange of Securities. Subject to the terms and conditions
----------------------
hereinafter set forth, on the Closing Date (as defined below), the Holding
Company shall cause to be issued and delivered to the Shareholders the class and
the number of shares of stock of the Holding Company (the "Shares") set forth
opposite their names on Schedule 1.1, which is attached hereto and made a part
------------
hereof, in exchange for which the Shareholders shall deliver to the Holding
Company all of the issued and outstanding stock of OWE.
1.2 Monogenesis Warrants. OWE has issued to Monogenesis warrants to
--------------------
purchase 600 of its shares of common stock which will be exchanged for warrants
to purchase 88,800 Common Shares of the Holding Company upon the terms and
conditions described in such warrants.
1.3 Issuance of Securities to Monogenesis. Prior to the exchange of
-------------------------------------
securities described in Section 1.1 above, the Holding Company shall issue to
Monogenesis 300,000 Common Shares upon receipt of the purchase price of $0.01
per share and 3,000,000 Warrants (in substantially the form attached hereto as
Exhibit 1.3) upon receipt of the purchase price of $0.001 per Warrant.
-----------
2
<PAGE>
1.4 Registration Statement. The Holding Company and OWE shall prepare
----------------------
and file the Registration Statement pursuant to the 1933 Act registering a total
of 5,434,652 Common Shares and 3,000,000 Warrants, which constitute 2,045,852 of
the 5,926,448 Common Shares to be issued to the Shareholders, the 300,000 Common
Shares and 3,000,000 Warrants to be issued to Monogenesis, the 88,800 Common
Shares underlying the Monogenesis warrants (including Common Shares to be
received upon conversion of the Class B Common Shares) and the 3,000,000 Common
Shares underlying the Warrants. The Shareholders shall receive the registered
shares as indicated on Schedule 1.1.
------------
1.5 Dispositions of Shares By the Shareholders. The parties desire that
------------------------------------------
this transaction qualify as a tax free reorganization under the Internal Revenue
Code of 1986, as amended. In furtherance thereof, the Shareholders shall not
dispose of any shares of the Holding Company stock received in the exchange if
such disposition would affect the tax-exempt nature of the transaction.
ARTICLE II
CLOSING
2.1 Time and Place. The closing of the transactions contemplated by this
--------------
Agreement (the "Closing") shall take place at the place and on such date and at
such time within ten business days after the date on which all of the conditions
set forth in Articles VIII and IX to each party's obligations hereunder have
been satisfied or waived, as set forth in a written notice from Monogenesis at
least five business days prior thereto; or on such other date and at such other
time and place as OWE and Monogenesis may mutually agree. The date on which the
Closing actually occurs is herein referred to as the "Closing Date."
2.2 Actions at the Closing. (a) At the Closing, the Shareholders shall
----------------------
deliver to the Holding Company and the Holding Company shall deliver to the
Shareholders the shares to be exchanged in accordance with Section 1.1 of this
Agreement. The Shareholders shall deliver the certificates representing all of
the issued and outstanding shares of stock of OWE to the Holding Company in
negotiable form or together with completed and executed stock powers
transferring such shares to the Holding Company. Upon receipt of such shares,
the Holding Company shall instruct the transfer agent to prepare and deliver
certificates representing the Shares.
(b) At the Closing, Monogenesis shall deliver to the Holding Company
and the Holding Company shall deliver to Monogenesis, the warrants to be
exchanged in accordance with Section 1.2 of this Agreement. Monogenesis shall
deliver the certificates representing all of the issued and outstanding warrants
of OWE held by it to the Holding Company in negotiable form or together with
completed and executed assignments transferring such warrants to the Holding
Company. Upon receipt of such warrants, the Holding Company shall prepare and
deliver certificates representing the new warrants.
2.3 Holding Company Directors. The Board of Directors of the Holding
-------------------------
Company shall have the number of directors designated by OWE and shall consist
of the individuals designated by OWE.
3
<PAGE>
2.4 Simultaneous Actions. All proceedings to be taken and all documents
--------------------
to be executed and delivered by the parties at the Closing shall be deemed to
have been taken and executed simultaneously and no proceedings shall be deemed
taken nor any documents executed or delivered until all have been taken,
executed and delivered.
ARTICLE III
REPRESENTATIONS AND WARRANTS OF OWE
OWE represents and warrants to Monogenesis, all of which representations
and warranties shall be true on the Closing Date and shall survive the Closing,
that:
3.1 Organization. OWE is a corporation duly organized, validly existing
------------
and in good standing under the laws of the State of California and has the power
to own its property and carry on its business as it is now being conducted. OWE
is duly qualified and in good standing to do business in every jurisdiction in
which such qualification is necessary and each of such jurisdictions is listed
on Schedule 3.1 attached hereto. Copies of the Articles of Incorporation and
------------
the Bylaws of OWE, which have been furnished by OWE to Monogenesis, are true and
correct copies of said documents including all amendments to the date hereof.
The offices and directors of OWE are listed on Schedule 3.1.
------------
3.2 Capitalization. OWE has authorized 100,000 shares of Common Stock
--------------
which have no par value and 50,000 shares of Preferred Stock which have no par
value. Of such shares, 30,000 shares of Common Stock, 1,000 shares of Series C
Preferred Stock, 1,500 shares of Series D Preferred Stock, 1,200 shares of
Series E Preferred Stock, 1,250 shares of Series F Preferred Stock, 2,000 shares
of Series G Preferred Stock, 550 shares of Series I Preferred Stock, 1,000
shares of Series K Preferred Stock and 183 shares of Series L Preferred Stock
are issued and outstanding and have been and will be duly authorized, validly
issued, fully paid and nonassessable. A list of all shareholders of OWE and the
number and class of shares held by each such shareholder is included on Schedule
--------
3.2. Except for the warrants issued to Monogenesis and as set forth on Schedule
--- --------
3.2 hereto and described herein, there is no: (i) outstanding security
---
convertible into or exchangeable for the Common Stock of OWE; (ii) option,
warrant, put, call or other right to purchase or subscribe to Common Stock of
OWE; or (iii) contract, commitment, agreement, understanding or arrangement of
any kind relating to the issuance or disposition of Common Stock of OWE or the
issuance or disposition of any security convertible into Common Stock of OWE.
OWE's records reflect the ownership of all issued and outstanding shares of its
stock by the Shareholders.
3.3 Subsidiaries. OWE has no subsidiaries and owns no stock, partnership
------------
or other equity interest in any other entity.
3.4 Authority. OWE has full power to execute and perform this Agreement.
---------
The execution and delivery of this Agreement has been duly authorized by all
necessary corporate and other actions. Neither the execution nor delivery of
this Agreement nor the performance, observation or compliance with its terms and
conditions will violate any provision of law, any order of court or other
governmental agency, the Articles of Incorporation or Bylaws of OWE, or any
indenture, agreement or other instrument to which OWE is a party, or by which it
is bound or by which any of its property is bound. No consent to the
4
<PAGE>
performance, observation or compliance with the terms and conditions of this
Agreement by OWE is required from any third party.
3.5 Financial Statements. OWE has provided Monogenesis with true and
--------------------
complete copies of the following (collectively, the "Financial Statements"):
(a) the audited balance sheets of OWE as of March 31, 2000, 1999,
1998 and 1997, and the related audited statements of earnings and retained
earnings and cash flow for the fiscal years then ended, and notes related
thereto; and
(b) the unaudited balance sheet (the "Balance Sheet") of OWE as of
September 30, 2000 (the "Balance Sheet Date") and the related unaudited
statement of earnings for the three months then ended, prepared by OWE and
accompanied by a certificate in the form of Exhibit 3.5 hereto executed by the
-----------
persons indicated on said Exhibit.
The Financial Statements either eliminate or clearly disclose all transactions
between OWE, the Shareholders and their affiliates. Except as otherwise noted
in the Financial Statements, the Financial Statements are complete and present
fairly the financial position of OWE and the results of its operations as of the
dates thereof and for the periods covered thereby in conformity with generally
accepted accounting principles applied on a consistent basis.
3.6 Absence of Undisclosed Liabilities. To the Best Knowledge (as defined
----------------------------------
in Section 3.20 below) of OWE, at the Balance Sheet Date (i) OWE had no
liabilities or obligations of any nature (matured or unmatured, fixed or
contingent) which were not provided for or disclosed on the Balance Sheet, (ii)
all reserves and allowances provided on the Balance Sheet were adequate for the
purposes indicated therein and (iii) there were no loss contingencies (as such
term is used in Statement of Financial Accounting Standards No. 5 issued by the
Financial Accounting Standards Board (FASB)) which were not adequately provided
for in the Balance Sheet.
3.7 Absence of Changes. Since the Balance Sheet Date, OWE's business has
------------------
operated in the ordinary course and there has not been (i) any adverse change in
its condition (financial or otherwise), assets, liabilities, earnings or
business; (ii) any obligation or liability (whether absolute, accrued,
contingent or otherwise and whether due or to become due) incurred, or any
transaction, contract or commitment entered into, other than items incurred or
entered into (as the case may be) in the ordinary course of the business; (iii)
any amendment or termination of a material contract, license, lease, commitment
or other agreement to which OWE is a party, except in the ordinary course of
business and consistent with past practice; (iv) any license, sale, transfer,
pledge, mortgage or other disposition of any tangible or intangible asset or
Intellectual Property (as defined in Section 3.13 below) except sales of
mortgages or other property in the ordinary course of business and consistent
with past practice; (v) any failure to operate its business in the ordinary
course consistent with past practice, including, but not limited to, any failure
to make capital expenditures or investments necessary to continue business in
the ordinary course or any failure to pay trade accounts payable when due; or
(vi) any dividend or other distribution declared or paid or any change in its
outstanding capital stock except as disclosed to Monogenesis.
5
<PAGE>
3.8 Title to Assets. OWE has good and marketable title to all of its
---------------
assets, free and clear of all mortgages, liens, pledges, charges, security
interests, rights of way, options, rights of first refusal, conditions,
restrictions or encumbrances of any kind or character, whether or not relating
to the extension of credit or the borrowing of money (collectively,
"Encumbrances"), except for (i) the Encumbrances disclosed in the Financial
Statements and (ii) liens for taxes and governmental charges not yet payable
without penalty. There is no asset used or required by OWE in the conduct of
its business which is not either owned by it or licensed or leased to it.
3.9 Litigation. Except as disclosed in the Registration Statement, there
----------
are no (i) audits, inspections, actions, suits, claims, investigations or legal,
administrative or arbitration proceedings pending or threatened against OWE,
whether at law or in equity, whether civil or criminal in nature or whether
before or by any federal, state, municipal or other governmental department,
commission, board, bureau, agency or instrumentality, domestic or foreign, nor,
to the Best Knowledge of OWE, does any basis exist therefor or (ii) judgments,
decrees, injunctions or orders of any court, governmental department,
commission, agency, instrumentality or arbitrator against OWE.
3.10 Compliance; Governmental Authorization. (a) OWE has complied with
--------------------------------------
all federal, state, territorial, local or foreign laws, ordinances, regulations
or orders applicable to its business or assets, including, by way of
description, and not limitation, matters relating to the environment, anti-
competitive practices, discrimination, employment, health and safety, taxes,
issuance of securities, customs duties and requirements and foreign practices.
OWE has all federal, state, territorial, local and foreign governmental licenses
and permits necessary in the conduct of its business as presently conducted,
which licenses and permits are in full force and effect, and no violations are
outstanding or uncured with respect to any such licenses or permits and no
proceeding is pending or threatened to revoke or limit any of them. Such
licenses, consents and permits shall not be affected in any respect by the
transactions contemplated hereby.
(b) As used in this Agreement, "Hazardous Substance" shall mean and
include all hazardous or toxic substances, wastes or materials, any pollutants
or contaminants (including, without limitation, all oil and petroleum of any
kind and in any form, asbestos and raw materials which include hazardous
constituents), or any other similar substances, or materials which are included
under or regulated by any applicable local, state, federal or foreign law, rule
or regulation pertaining to environmental regulation, contamination, clean-up or
disclosure, including, without limitation, the Clean Air Act, the Federal Water
Pollution Control Act, the Comprehensive Environmental Response, Compensation
and Liability Act of 1980, the Superfund Amendments and Reauthorization Act of
1986, the Resource Conservation and Recovery Act of 1976, the Toxic Substances
Control Act, the Federal Insecticide, Fungicide and Rodenticide Act, the
Occupational Safety and Health Act, the Emergency Planning and Community Right-
to-Know Act of 1986, and all comparable applicable state or local laws, orders
and regulations, as any of the foregoing has heretofore been amended.
(c) OWE hereby warrants to Monogenesis that OWE and the supervisory
employees, officers and directors of OWE have no knowledge of the presence,
storage, disposition, generation, treatment, release or discharge of any
Hazardous Substance on, under or about the assets owned by OWE or the land and
buildings on and in which OWE currently conducts or previously conducted its
operations except in accordance with applicable laws.
6
<PAGE>
3.11 Labor Relations; Employees. OWE is in compliance with all applicable
--------------------------
federal, state, territorial, local and foreign laws and regulations respecting
labor, employment and employment practices, terms and conditions of employment
and wages and hours. There is no unfair labor practice complaint against OWE
pending before any state, local or foreign agency. There is no labor strike,
dispute, slowdown, stoppage or organizational effort or similar activity
actually pending or, to the Best Knowledge of OWE, threatened involving OWE; no
representation question exists respecting the employees of OWE; and no
collective bargaining agreement presently covers any employees of OWE, nor is
any currently being negotiated.
3.12 Employee Benefit Plans. Schedule 3.12 attached hereto lists all
---------------------- -------------
"employee pension benefit" plans (as defined in Section 3(2) of the Employee
Retirement Income Security Act of 1974, as amended ("ERISA")), all "employee
welfare benefit" plans (as defined in Section 3(1) of ERISA) and any other
qualified or non-qualified plans, programs or letters of commitment promising
current or future benefits or deferred compensation (individually, a "Plan" and,
collectively, the "Plans") maintained by OWE. All Plans which are "employee
pension benefit" plans are so indicated on Schedule 3.12. All reports,
-------------
statements, returns and other information required to be furnished or filed with
respect to the Plans have been furnished or filed, or both, and all required
records have been maintained. There are no actions, suits or claims pending, or
to the Best Knowledge of OWE, threatened against, involving or affecting any
Plan. OWE has no material liability, civil or criminal, under any provision of
ERISA or any other applicable statute or rule of law with respect to the Plans.
There are no violations of the health care continuation coverage requirements of
the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended ("COBRA")
with respect to employees of OWE or any qualified beneficiaries of such
employees.
3.13 Intellectual Property. Set forth on Schedule 3.13 is a list and a
--------------------- -------------
brief description or identification of all material intellectual property rights
owned, leased or licensed by OWE or used in connection with its business,
including without limitation all patents, patent applications, trade names,
fictitious or assumed names, trademarks, trademark applications, service marks,
service mark applications, copyrights, copyright applications, patterns,
inventions, trade secrets, proprietary processes and formulae, license
agreements, and all other similar proprietary rights, whether patentable or
unpatentable (collectively, the "Intellectual Property"). Except only as set
forth on Schedule 3.13, OWE is not a licensor or licensee in respect of any
-------------
Intellectual Property which is material to its business. OWE owns or possesses
adequate licenses or other rights to use all Intellectual Property necessary to
conduct its business as now operated and all of such Intellectual Property is
owned outright by OWE except as is otherwise specifically noted on Schedule
--------
3.13. To the Best Knowledge of OWE, there is no infringement, misappropriation
----
or other misuse being made by any other party of the Intellectual Property. No
claim is pending or threatened to the effect that the present or past operations
of OWE infringe or conflict with the asserted rights of others in respect of any
Intellectual Property, and no claim is pending or threatened to the effect that
any of such Intellectual Property is invalid or unenforceable.
3.14 Accounts and Notes Receivable. Except as otherwise reflected in the
-----------------------------
Financial Statements, all unpaid accounts and notes receivable outstanding at
the date hereof constitute, and those outstanding at the Closing Date will
constitute, valid and enforceable claims arising in bona fide transactions in
---- ----
the ordinary course of business, except as enforceability is limited by
applicable bankruptcy, reorganization, insolvency, moratorium, fraudulent
conveyance or similar laws affecting the enforcement
7
<PAGE>
of creditors rights generally. Except as described in the Financial Statements,
there is (i) no account or note debtor who has refused or threatened to refuse
to pay its obligations or who has or threatened to set-off such obligations for
any reason, (ii) no account or note debtor who is to OWE's Best Knowledge
insolvent or bankrupt and (iii) no account or note receivable pledged to any
third party. The reserves and allowances provided for on the Balance Sheet have
been established on the basis of historical experience in accordance with
generally accepted accounting principles. To the Best Knowledge of OWE, no
material customer of OWE is currently a debtor in any proceeding under the
Federal Bankruptcy Code, a state insolvency law or other similar law.
3.15 Loan Inventories. The loan inventories of OWE are, and at the
----------------
Closing Date will be, (i) of a quantity which is reasonable in the circumstances
of OWE; and (ii) of a quality which is substantially similar to the historical
quality of OWE's inventory.
3.16 Tax Matters. For purposes of this Agreement, the term "Taxes" means
-----------
all taxes of any kind or nature, including but not limited to federal, state,
local and foreign income taxes, withholding taxes, branch profit taxes, gross
receipts taxes, franchise taxes, sales and use taxes, business and occupation
taxes, property taxes, VAT, custom duties or imposts, stamp taxes, excise taxes,
payroll taxes, intangible taxes and capital taxes and any penalties or interest
thereon. OWE has filed within the time and in the manner prescribed by law all
tax returns and reports required to be filed by it under the laws of the United
States and each state or other jurisdiction in which it conducts business
activities requiring the filing of tax returns or reports. OWE has paid or set
up adequate reserves in the Balance Sheet in respect of all Taxes. There are no
tax liens, whether imposed by the United States, any state, local, foreign or
other taxing authority, outstanding against OWE or its assets. All Taxes and
assessments that OWE is required to withhold or to collect have been duly
withheld or collected and all withholdings and collections have either been duly
and timely paid over to the appropriate governmental authorities or are,
together with the payments due or to become due in connection therewith, duly
reflected on the Balance Sheet in accordance with generally accepted accounting
principles.
3.17 Books and Records. The books of account and other corporate
-----------------
financial records of OWE are in all material respects complete and correct, have
been maintained in accordance with good business practices and matters contained
therein are appropriately and accurately reflected in the Financial Statements.
The corporate record book of OWE contains true and complete copies of all
meetings of its shareholders and directors.
3.18 Disclosure. Neither this Agreement (including the Schedules and
----------
Exhibits attached hereto) nor any other document, certificate or statement
furnished to Monogenesis by or on behalf of OWE in connection with the
transactions contemplated hereby, when considered in the aggregate with all
other such documents, certificates or statements, contains any untrue statement
of a material fact or omits to state a material fact necessary in order to make
the statements contained herein and therein not misleading.
3.19 Best Knowledge of OWE. OWE represents and warrants that each time a
---------------------
representation and warranty is based on "Best Knowledge" that the officers of
OWE have made a duly diligent investigation and inquiry.
8
<PAGE>
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF THE SHAREHOLDERS
The Shareholders, jointly and severely, represent and warrant, all of
which representations and warranties shall be true on the Closing Date and shall
survive the Closing, that:
4.1 Authority. The Shareholders have full power and authority to execute
---------
and perform this Agreement and to exchange the shares of stock of OWE upon the
terms provided in this Agreement. The execution and delivery of this Agreement
has been duly authorized by the Shareholders. Neither the execution nor
delivery of this Agreement nor the performance, observation or compliance with
its terms and provisions will violate any provision of law, any order of court
or other governmental agency, or any indenture, agreement or other instrument to
which any Shareholder is a party, or by which such Shareholder or such
Shareholder's property is bound. No consent to the performance, observation or
compliance with the terms and conditions of this Agreement by the Shareholders
is required from any third party.
4.2 Stock Ownership. All of the issued and outstanding stock of OWE is
---------------
directly owned by the Shareholders, as indicated herein, free and clear of all
liens, encumbrances, security interests, charges, pledges, options, restrictions
on transfer, rights of refusal or other adverse claims of any kind. No person
owns or has any beneficial interest in any stock except the Shareholders. The
Shareholders have good and marketable title to the shares of stock of OWE being
transferred. The Shareholders have not transferred or assigned, or entered into
any agreement or understanding to transfer or assign, any of the stock of OWE or
any of the voting rights pertaining to such shares except as described herein.
4.3 Investment Representations. (a) The Shareholders have received such
--------------------------
material information as has been requested for purposes of becoming fully
familiar with the financial condition of OWE and the expected condition of the
Holding Company, the administration of their business affairs, and their
prospects for future business.
(b) The Shareholders are fully aware and have been advised that the
securities received pursuant to this Agreement are speculative in nature and
that neither OWE nor the Holding Company make any assurance whatever concerning
the present or prospective value of the securities.
(c) The Shareholders understand that, with the exception of the
2,045,852 Common Shares which will be registered pursuant to the 1933 Act, the
Common Shares, the Class B Common Shares and the Preferred Shares to be received
by the Shareholders pursuant to this Agreement will not be registered under the
1933 Act, on the ground that the securities are being issued and sold in a
transaction not involving any public offering and that, consequently, the
transaction is exempt from registration under the 1933 Act by virtue of the
provisions of Section 4(2) thereof; nor are the securities to be registered
under the securities laws of any state on the ground that the transaction is
exempt, or registration of securities is not required.
(d) The Shareholders understand that the issuance of the Holding
Company stock has not been qualified with the Commissioner of Corporations of
the State of California and the issuance of
9
<PAGE>
such securities, or the payment or receipt of any part of the consideration
therefor, prior to such qualification is unlawful, unless the sale of securities
is exempt from qualification by (S)(S) 25200, 25102 or 25105 of the California
Corporation Code and that the rights of all parties to this Agreement are
expressly conditioned upon such qualification being obtained, unless the
issuance is so exempt.
(e) The Shareholders understand that the reliance of OWE and the
Holding Company upon the above exemptions is predicated in part on the
representation of the Shareholders that such unregistered securities are being
acquired for the account of the Shareholders with no present intention of
reselling or otherwise distributing the same.
(f) The Shareholders understand that they will not be able to dispose
of any shares acquired pursuant to this Agreement, except such shares as are
registered as described in Article I, or any interest therein unless and until
such shares or interests have been registered under the 1933 Act and applicable
state securities laws or the disposition is exempt from registration or
qualification under applicable securities laws and, if requested by the Holding
Company, the Holding Company has received an opinion from counsel satisfactory
to it that registration or qualification is not required in connection with such
disposition. The Shareholders understand that the Holding Company will prohibit
transfers of the shares which are not registered as described in Article I in
the absence of registration or the mentioned exemptions and a restrictive legend
will be placed on the Class B Common Shares, the Preferred Shares and on the
Common Shares received by the Shareholders which are not registered as described
in Article I reflecting these restrictions.
(g) The Shareholders represent that they will not, directly or
indirectly, bid for, purchase or attempt to induce any other person to take any
of the aforementioned actions at any time during which they are involved in a
distribution and during any restricted period prior to the beginning of the
distribution as required under Regulation M promulgated under the Securities
Exchange Act of 1934.
ARTICLE V
REPRESENTATIONS AND WARRANTIES OF MONOGENESIS
Monogenesis represents and warrants, all of which representations and
warranties shall be true on the Closing Date and shall survive the Closing,
that:
5.1 Organization. Monogenesis is a corporation duly organized, validly
------------
existing and in good standing under the laws of the State of Delaware and has
the corporate power to carry on its business as it is now being conducted.
5.2 Authority. Monogenesis has the full power to execute and perform
---------
this Agreement. The execution and delivery of this Agreement has been duly
authorized by all necessary corporate and other actions. Neither the execution
nor delivery of this Agreement nor the performance, observance or compliance
with its terms and conditions will violate any provision of law, any order of
court or other governmental agency, the Certificate of Incorporation or Bylaws
of Monogenesis or any indenture, agreement or other instrument to which
Monogenesis is a party, or by which it is bound. No consent to
10
<PAGE>
the performance, observation or compliance with the terms and conditions of this
Agreement by Monogenesis is required from any third party.
5.3 Shareholders. Monogenesis has in excess of 1,000 shareholders.
------------
ARTICLE VI
COVENANTS OF OWE
OWE hereby covenants and agrees with Monogenesis as follows:
6.1 Conduct of Business Until Closing Date. Except as permitted or
--------------------------------------
required hereby or as Monogenesis may otherwise consent in writing, between the
date hereof and the Closing Date, OWE shall:
(a) operate its business only in the usual, regular and ordinary
manner as such business was conducted prior to the Balance Sheet Date and, to
the extent consistent with such operation, use its best efforts to (i) preserve
the present business organization intact, (ii) keep available the services of
the present employees, and (iii) preserve the present business relationship with
customers, suppliers and others having business dealings with it;
(b) maintain all properties necessary for the conduct of the
business, whether owned or leased, in substantially the same condition as they
now are (reasonable wear and tear which are not such as to materially adversely
affect operations and damage due to unavoidable casualty excepted);
(c) neither (i) encumber, mortgage or voluntarily subject to lien,
except for liens created pursuant to existing loan agreements or made in the
ordinary course of business, any of the properties or assets, (ii) convey,
transfer or acquire any material asset or property other than in the ordinary
course of business, nor (iii) except in the ordinary course of business, incur
any material fixed or contingent obligation or enter into any material
agreement, commitment or other transaction or arrangement; and
(d) neither declare, set aside, pay or make any dividend or other
distribution or payment on or in respect of shares of its stock, nor directly or
indirectly redeem, retire, purchase or otherwise acquire any of its stock.
6.2 Access to Properties and Records. OWE shall give to Monogenesis and
--------------------------------
its representatives reasonable access during normal business hours to OWE's
properties, personnel, books, tax returns, contracts, commitments and records
and the right to make copies thereof. OWE shall furnish to Monogenesis and such
representatives all such additional documents and financial and other
information as Monogenesis or its representatives may from time to time
reasonably request and permit Monogenesis and such representatives to examine
all records and working papers relating to the preparation, review and audits of
OWE's financial statements and tax returns.
6.3 Advice of Changes. Between the date hereof and the Closing Date, OWE
-----------------
shall advise Monogenesis promptly in writing of any fact of which any OWE
becomes aware, which, if known at the date hereof, would have been required to
be set forth or disclosed in or pursuant to this Agreement.
11
<PAGE>
6.4 Conduct. Except as permitted or required hereby or as OWE may notify
-------
Monogenesis in writing, OWE shall not enter into any transaction, take any
action, or fail to take any action, which would result in any of the
representations and warranties of OWE contained in this Agreement or in any
Schedule or Exhibit hereto not being true and correct at and as of the time
immediately after such transaction has been entered into or such event has
occurred and on the Closing Date.
6.5 Approvals, Consents. OWE shall obtain in writing prior to the
--------------------
Closing Date all approvals, consents and waivers, required to be obtained by OWE
in order to effectuate the transactions contemplated hereby, and shall deliver
to Monogenesis copies thereof, reasonably satisfactory in form and substance to
Monogenesis.
ARTICLE VII
COVENANTS OF MONOGENESIS
Monogenesis hereby covenants and agrees with OWE as follows:
7.1 Confidentiality; Return of Documents. Unless and until the
------------------------------------
transactions contemplated by this Agreement are consummated, Monogenesis shall
keep in confidence all proprietary and financial information of OWE, and shall
not, except to the extent required by law or to the extent any such information
is otherwise publicly available, without the prior written consent of OWE,
reveal any such financial or proprietary information to any third party other
than securities regulatory authorities in connection with the Registration
Statement or counsel, accountants or experts retained by Monogenesis who shall
be bound by the same restrictions. If the transactions contemplated by this
Agreement are not consummated, at OWE's request, Monogenesis shall return to OWE
all documents supplied to Monogenesis by OWE pursuant to the provisions of this
Agreement.
ARTICLE VIII
CONDITIONS TO OBLIGATIONS OF MONOGENESIS
The obligation of Monogenesis to perform as provided in this Agreement is
subject to the satisfaction at or prior to the Closing Date of the following
conditions unless waived by Monogenesis in its sole discretion:
8.1 Accuracy of Representations and Warranties. The representations and
------------------------------------------
warranties of OWE and the Shareholders contained in this Agreement and in any
Schedule or Exhibit hereto shall be true and accurate in all material respects
on and as of the Closing Date, with the same force and effect as if made on the
Closing Date, except as affected by transactions required or permitted hereby,
and except that any such representation or warranty made as of a specified date
(other than the date of this Agreement) shall have been true and accurate in all
material respects on and as of such date.
8.2 Performance of Agreements. OWE and the Shareholders shall have
-------------------------
performed and complied with all covenants, obligations and agreements to be
performed or complied with, on or before the Closing Date pursuant to this
Agreement or any Schedule or Exhibit hereto, including, but not limited to, the
transfer of the Shares to the Holding Company.
12
<PAGE>
8.3 Officer's Certificate. Monogenesis shall have received an accurate
---------------------
certificate of a duly authorized officer of OWE, dated the Closing Date,
satisfactory in form and substance to Monogenesis, certifying the fulfillment of
the matters specified in Sections 8.1 and 8.2.
8.4 Secretary's Certificate. Monogenesis shall have received an accurate
-----------------------
certificate of the Secretary of OWE, dated the Closing Date, satisfactory in
form and substance to Monogenesis, with respect to the resolutions adopted by
the Board of Directors of OWE approving this Agreement and the transactions
contemplated hereby.
8.5 Consents, Authorizations. All consents, authorizations, orders or
------------------------
approvals of, and filings or registrations with and the expiration of all
waiting periods imposed by, any third party, including, without limitation, any
federal, state or local commission, board or other regulatory body, lender,
lessor, licensor or supplier which are required for or in connection with the
execution and delivery of this Agreement by OWE and the Shareholders and the
consummation of the transactions contemplated hereby shall have been duly
obtained or made and shall be in full force and effect.
8.6 Legislation. No federal, state or local statute, rule or regulation
-----------
shall have been enacted after the date of this Agreement which prohibits,
restricts, delays or materially adversely affects the business of OWE or the
consummation of the transactions contemplated by this Agreement or any of the
conditions to the consummation of such transactions. No temporary restraining
order or injunction shall be in effect, or threatened by a governmental agency,
restraining the consummation of the transactions contemplated hereby.
8.7 Monogenesis Warrants. OWE shall have sold to Monogenesis warrants to
--------------------
purchase 600 of its shares of common stock.
8.8 Issuance, Registration and Distribution of Shares and Warrants. The
--------------------------------------------------------------
Holding Company shall have been formed and shall have taken all steps necessary
to issue the Shares and Warrants in accordance with this Agreement. Monogenesis
shall have resolved to distribute to each of its shareholders 100 Common Shares
and 1,100 Warrants of the Holding Company to be issued to Monogenesis for each
share of stock of Monogenesis held by such shareholder. The Registration
Statement shall have been filed registering 2,045,852 of the Common Shares to be
issued to the Shareholders, all of the Common Shares to be issued to
Monogenesis, all of the Warrants and all of the Common Shares underlying the
Warrants, and such Registration Statement shall have become effective.
8.9 Good Standing Certificates. Monogenesis shall have received
--------------------------
certificates acceptable to it from the Secretary of State of (i) the
jurisdiction in which OWE is incorporated, certifying that OWE is in good
standing under the laws of such jurisdiction and a certified copy of the
Articles of Incorporation of OWE and all amendments, and (ii) each jurisdiction
in which OWE is qualified to do business as a foreign corporation, certifying
that OWE is so qualified and in good standing.
8.10 Financial Statements. Monogenesis shall have received: (i) the
--------------------
audited balance sheet of OWE of March 31, 2000 and the related audited
statements of earnings, retained earnings and cash flows for the fiscal year
then ended; and (ii) the unaudited balance sheet of OWE as of the quarter-end
13
<PAGE>
immediately preceding the Closing Date (or the prior quarter-end if the Closing
occurs within thirty-five days of the end of a quarter), and the related
unaudited statements of earnings, retained earnings and cash flows for the
portion then ended of the fiscal year commencing April 1, 2000, presented on a
comparative basis with financial statements of the same portion of the preceding
fiscal year, prepared by OWE and accompanied by a certificate in the form of
Exhibit 3.5 attached hereto executed by the persons indicated on said Exhibit.
-----------
Such statements for the fiscal year commencing April 1, 2000 shall not differ
from those for the comparable period of the preceding fiscal year in any
materially adverse respect.
8.11 Casualty. There shall have not occurred any fire, flood, earthquake
--------
or other casualty to assets of OWE resulting in a cost of repair or replacement
of more than $25,000 in excess of applicable insurance coverage.
ARTICLE IX
CONDITIONS TO OBLIGATIONS OF OWE AND THE SHAREHOLDERS
The obligation of OWE and the Shareholders to perform their obligations
under this Agreement is subject to the satisfaction at or prior to the Closing
Date of the following conditions unless waived by OWE and the Shareholders in
their sole discretion:
9.1 Accuracy of Representations and Warranties. The representations and
------------------------------------------
warranties of Monogenesis contained in this Agreement or in any Schedule or
Exhibit hereto shall be true and accurate in all material respects on and as of
the Closing Date, with the same force and effect as if made on the Closing Date,
except as affected by transactions required or permitted hereby, and except that
any such representation or warranty made as of a specified date (other than the
date of this Agreement), shall have been true and accurate in all material
respects on and as of such date.
9.2 Performance of Agreements. Monogenesis shall have performed and
-------------------------
complied in all material respects with all covenants, obligations and agreements
to be performed or complied with by it on or before the Closing Date pursuant to
this Agreement or any Schedule or Exhibit hereto.
9.3 Officer's Certificate. OWE and the Shareholders shall have received
---------------------
an accurate certificate, dated the Closing Date, of a duly authorized officer of
Monogenesis, satisfactory in form and substance to OWE and the Shareholders,
certifying as to the fulfillment of the matters specified in Sections 9.1 and
9.2.
9.4 Secretary's Certificate. OWE and the Shareholders shall have
-----------------------
received an accurate certificate, dated the Closing Date, of the Secretary of
Monogenesis, satisfactory in form and substance to OWE and the Shareholders,
with respect to the resolutions adopted by the Board of Directors of Monogenesis
approving this Agreement and the transactions contemplated hereby.
9.5 Consents, Authorizations. All consents, authorizations, orders or
------------------------
approvals of, and filings or registrations with, and the expiration of all
waiting periods imposed by any third party, including without limitation, any
federal, state or local commission, board or other regulatory body which are
required for or in connection with the execution and delivery by Monogenesis of
this Agreement and the
14
<PAGE>
consummation by Monogenesis of the transactions contemplated hereby shall have
been obtained or made and shall be in full force and effect.
9.6 Legislation. No federal, state or local statute, rule or regulation
-----------
shall have been enacted after the date of this Agreement which prohibits,
restricts, delays or materially adversely affects the consummation of the
transactions contemplated by this Agreement or any of the conditions to the
consummation of such transactions. No temporary restraining order or injunction
shall be in effect, or threatened by a governmental agency, restraining the
consummation of the transactions contemplated hereby.
9.7 Monogenesis Warrants. OWE shall have sold to Monogenesis warrants to
--------------------
purchase 600 of its shares of common stock.
9.8 Issuance, Registration and Distribution of Shares and Warrants. The
--------------------------------------------------------------
Holding Company shall have been formed and shall have taken all steps necessary
to issue the Shares in accordance with this Agreement. Monogenesis shall have
resolved to distribute to each of its shareholders 100 Common Shares and 1,100
Warrants of the Holding Company to be issued to Monogenesis for each share of
stock of Monogenesis held by such shareholder. The Registration Statement shall
have been filed registering 2,045,852 of the Common Shares to be issued to the
Shareholders, all of the Common Shares to be issued to Monogenesis, all of the
Warrants and all of the Common Shares underlying the Warrants, and such
Registration Statement shall have be become effective.
ARTICLE X
TERMINATION
10.1 Termination. This Agreement may be terminated at any time prior to
-----------
the Closing Date:
(a) by OWE or Monogenesis at any time after ___________, 2000;
provided, however, that if the Registration Statement has not become effective
and Monogenesis is diligently pursuing the registration of the Shares then
Monogenesis may extend such date beyond _________, 2000 to a date within ten
business days of the effective date, but not later than ___________, 2000;
(b) by Monogenesis, if the after tax earnings of OWE do not equal an
average of $________ per month for the period beginning immediately after the
end of the last fiscal year and ending on the day prior to the effective date of
the Registration Statement;
(c) by Monogenesis, if there has been a violation or breach by OWE
or the Shareholders of any material agreement, representation or warranty of any
of them contained in this Agreement and such violation or breach has not been
waived by Monogenesis, or, with respect to a violation or breach of an
agreement, cured within ten business days after the receipt of written notice
thereof; or
(d) by OWE, if there has been a violation or breach by Monogenesis
of any material agreement, representation or warranty of Monogenesis contained
in this Agreement and such violation or
15
<PAGE>
breach has not been waived by OWE or, with respect to a violation or breach of
an agreement, cured within ten business days after the receipt of written notice
thereof.
In the event of termination of this Agreement and abandonment of the
transactions contemplated hereby pursuant to this Section 10.1, written notice
thereof shall immediately be given to the other party and this Agreement shall
terminate and the transactions contemplated hereby shall be abandoned, without
further action by any of the parties hereto. The provisions of Sections 7.1,
12.1 and 12.2 shall survive any such termination.
ARTICLE XI
INDEMNIFICATION
11.1 Indemnification. (a) OWE and the Common Shareholders shall, jointly
---------------
and severally, indemnify, defend and save Monogenesis harmless from, against,
for and in respect of the following: (i) any damages, losses, obligations,
liabilities, claims, actions or causes of action sustained or suffered by
Monogenesis and arising from a breach of any representation, warranty, covenant
or agreement of OWE or the Shareholders contained in or made pursuant to this
Agreement (including the Schedules and Exhibits attached hereto), or in any
certificate, instrument or agreement delivered by OWE or the Shareholders
pursuant hereto or in connection with the transactions contemplated hereby; and
(ii) all reasonable costs and expenses (including, without limitation,
reasonable fees and expenses of attorneys, accountants and other professionals)
incurred by Monogenesis in connection with any action, suit, proceeding, demand,
investigation, assessment or judgment incident to any of the matters indemnified
against under this Section 11.1(a). Monogenesis shall not bring a claim,
demand, suit or cause of action against OWE under or pursuant to this Section
11.1(a) with respect to the representations and warranties set forth in Articles
III and IV hereof unless Monogenesis has first given OWE and the Common
Shareholders written notice, with reasonable specificity, of the existence of
any such claim, demand, suit or cause of action under this Agreement. Upon the
giving of such written notice as aforesaid, Monogenesis shall have the right, in
addition to all other remedies available to it, to commence legal proceedings
for the enforcement of its rights under this Agreement. Monogenesis, at its
option and with at least two days advance notice to the affected party, may
recover any such liability by set off against payments otherwise required to be
made by Monogenesis to such party pursuant to any agreement between Monogenesis
and such party.
(b) Monogenesis shall indemnify, defend and save OWE and the
Shareholders harmless from, against, for and in respect of the following: (i)
any damages, losses, obligations, liabilities, claims, actions or causes of
action sustained or suffered by OWE or the Shareholders and arising from a
breach of any representation, warranty, covenant or agreement of Monogenesis
contained in or made pursuant to this Agreement or in any certificate,
instrument or agreement delivered by it pursuant hereto or in connection with
the transactions contemplated hereby; and (ii) all reasonable costs and expenses
(including, without limitation, reasonable fees and expenses of attorneys,
accountants and other professionals) incurred by OWE or the Shareholders in
connection with any action, suit, proceeding, demand, investigation, assessment
or judgment incident to any of the matters indemnified against under this
Section 11.1(b). Neither OWE nor the Shareholders shall bring a claim, demand,
suit or cause of action against Monogenesis under or pursuant to this Section
11.1(b) unless such party has first given Monogenesis written notice, with
reasonable specificity, of the existence of any such claim, demand, suit
16
<PAGE>
or cause of action under this Agreement. Upon the giving of such written notice
as aforesaid, such party shall have the right, in addition to all other remedies
available to it, to commence legal proceedings for the enforcement of its rights
under this Agreement.
11.2 Third Party Claims. With respect to claims resulting from the
------------------
assertion of liability by third parties, the obligations and liabilities of the
party responsible for indemnification (the "Indemnifying Party") hereunder with
respect to indemnification claims by the party entitled to indemnity (the
"Indemnified Party") shall be subject to the following terms and conditions: (i)
the Indemnified Party shall give prompt written notice to the Indemnifying Party
of any assertion of liability by a third party which might give rise to a claim
by the Indemnified Party against the Indemnifying Party based on the indemnity
agreements contained in Section 11.1 hereof, stating the nature and basis of
said assertion and the amount thereof, to the extent known; and (ii) the
Indemnifying Party shall not make any settlement of any claims without the
written consent of the Indemnified Party; provided, however, that if an
Indemnified Party does not consent to a settlement proposed by the Indemnifying
Party and accepted by the adverse third party, the liability of the Indemnifying
Party shall be limited to the amount that would have been paid in such
settlement.
11.3 Remedies Cumulative. The remedies provided for in this Article XI
-------------------
shall be cumulative and shall not preclude assertion by the Indemnified Party of
any other rights or the seeking of any other remedies against the Indemnifying
Party.
11.4 Recoveries. In the event an Indemnified Party subsequently receives
----------
payment (including without limitation proceeds of insurance and payments on
accounts receivable) with respect to a matter for which it has been fully
indemnified by the Indemnifying Party, the Indemnified Party shall promptly pay
the amount of such payment up to the indemnification received, to the
Indemnifying Party.
ARTICLE XII
MISCELLANEOUS
12.1 Expenses; Transfer Taxes. All fees, costs and expenses incurred by
------------------------
OWE, the Shareholders or Monogenesis in connection with, relating to or arising
out of the preparation, execution, delivery and performance of this Agreement
and the consummation of the transactions contemplated hereby, including, without
limitation, organizational costs of the Holding Company, fees of the transfer
agent and legal and accounting fees and expenses relating to the formation of
the Holding Company and the preparation and filing of the Registration
Statement, shall be borne by OWE.
12.2 Binding Effect. This Agreement shall become binding and effective
--------------
when executed by the parties hereto. This Agreement shall not be assignable by
any party without the prior written consent of the other parties, except that
without relieving Monogenesis of any of its obligations under this Agreement,
Monogenesis may assign this Agreement to any of its affiliates. Subject to the
foregoing, this Agreement shall be binding upon, inure to the benefit of, and be
enforceable by, the respective successors, heirs, legal representatives and
assigns of the parties hereto. This Agreement constitutes an agreement among
the parties hereto and none of the agreements, covenants, representations or
warranties contained herein shall be for the benefit of any third party not a
party to this Agreement.
17
<PAGE>
12.3 Entire Agreement; Amendments. This Agreement (including the
----------------------------
Schedules and Exhibits attached hereto) contains the entire understanding of the
parties with respect to its subject matter. This Agreement supersedes all prior
agreements and understandings between the parties with respect to the subject
matter hereof. This Agreement may be amended only by a written instrument duly
executed by the parties, and any condition to a party's obligations hereunder
may only be waived in writing by such party.
12.4 Headings. The article and section headings contained in this
--------
Agreement are for reference purposes only and shall not affect in any way the
meaning or interpretation of this Agreement.
12.5 Notices. All notices, claims, certificates, requests, demands and
-------
other communications hereunder shall be in writing and shall be deemed given if
delivered personally, if mailed (by registered or certified mail, return receipt
requested and postage prepaid), if sent by reputable overnight courier service
for next business day delivery, or if sent by facsimile transmission, as
follows:
if to OWE, to: Marshall L. Stewart, Chief Executive Officer
Daryl Meddings, Chief Financial Officer
Ocean West Enterprises, Inc..
15991 Redhill Avenue, Suite 110
Tustin, California 92780
Telephone: (800) 500-6232
Facsimile: (714) 566-29201
if to Monogenesis to: Scot D. Walker, President
Monogenesis Corporation
Drawer 88, Walker Creek Road
Walker, West Virginia 26180-9948
Telephone: (800) 543-8620
Facsimile: (800) 543-8619
with a copy to: Lynn H. Wangerin, Esq.
Ogden Newell & Welch
1700 Citizens Plaza
500 West Jefferson Street
Louisville, Kentucky 40202-2874
Telephone: (502) 582-1601
Facsimile: (502) 581-9564
if to the Shareholders, to: such Shareholder's address set forth on the
books of OWE
18
<PAGE>
or to such other address as the party to whom notice is to be given may have
furnished to the other party in writing in accordance herewith. Any such
communication shall be effective on the date of receipt (or, if received on a
non-business day, on the first business day after the date of receipt).
12.6 Publicity. The parties agree that, except as otherwise required
---------
by law, the issuance of any reports, statements or releases pertaining to this
Agreement or the transactions contemplated hereby is subject to mutual consent.
12.7 Governing Law. This Agreement shall be governed by and construed
-------------
in accordance with the internal laws of the State of Delaware (without giving
effect to its laws regarding conflicts of law).
12.8 Waivers. Any provision of this Agreement may be waived only by a
-------
written instrument executed by the party to be charged with such waiver. The
waiver by any party hereto of a breach of any provision of this Agreement shall
not operate or be construed as a waiver of any subsequent breach.
12.9 Defined Terms. Throughout this Agreement various terms have been
-------------
defined by being enclosed in quotation marks, usually in parentheses, and used
with their initial letters capitalized. Unless the context otherwise requires,
such defined terms shall have their designated meaning whenever used in this
Agreement or any attached schedules.
12.10 Fees. If there is any litigation between the parties related to
----
this Agreement or the transactions contemplated by this Agreement, the
prevailing party shall be entitled to recover all reasonable costs and expenses
(including, without limitation, reasonable fees and expenses of attorneys,
accountants and other professionals).
12.11 Counterparts. This Agreement may be signed by each party upon a
------------
separate copy or separate signature page, and any combination of separate copies
signed by all parties or including signature pages so signed will constitute a
single counterpart of this Agreement. This Agreement may be signed in any
number of counterparts, each of which will be deemed to be an original, but all
of which together will constitute one and the same agreement. It will not be
necessary, in proving this Agreement in any proceeding, to produce or account
for more than one counterpart of this Agreement. This Agreement will become
effective when one or more counterparts have been signed by each party, and
delivered to the other parties, respectively. Any party may deliver an executed
copy of this Agreement (and an executed copy of any documents contemplated by
this Agreement) by facsimile transmission to another party, and such delivery
will have the same force and effect as any other delivery of a manually signed
copy of this Agreement (or such other document).
19
<PAGE>
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
executed and delivered on the date first above written.
Ocean West Enterprises, Inc.
By: ____________________________________
Title:____________________________________
Monogenesis Corporation
By: ____________________________________
Scot D. Walker, President
The Common Shareholders:
_________________________________________
Marshall L. Stewart
_________________________________________
Daryl S. Meddings
Agape Foundation Trust
By: ___________________________________
Title:___________________________________
20
<PAGE>
SCHEDULE 1.1
Holding Company Stock To Be Issued to the
-----------------------------------------
Shareholders and Pursuant to the Monogenesis Warrants
-----------------------------------------------------
<TABLE>
<CAPTION>
---------------------------------------------------------------------------------------------
Restricted Registered Class B
Common Common Common Preferred
Name Shares Shares Shares Shares
---------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
Daryl S. Meddings 1,708,035 569,345 102,936 -0-
---------------------------------------------------------------------------------------------
Marshall L. Stewart 1,699,035 566,345 102,936 -0-
---------------------------------------------------------------------------------------------
Agape Foundation Trust 473,526 157,842 -0- -0-
---------------------------------------------------------------------------------------------
Cheyenne Properties, Inc. -0- 480,000 -0- -0-
---------------------------------------------------------------------------------------------
Tracy A. Jochen -0- 118,400 -0- -0-
---------------------------------------------------------------------------------------------
Monogenesis -0- 88,800 -0- -0-
---------------------------------------------------------------------------------------------
Ronald C. and Judy M. Meddings Series E- 680
-0- 40,000 -0- Series F-1, 050
---------------------------------------------------------------------------------------------
Kingsley and Nancy Cannon -0- 29,920 -0- -0-
---------------------------------------------------------------------------------------------
Kevin P. Burke -0- 14,800 -0- -0-
---------------------------------------------------------------------------------------------
Thomas G. Melsheimer -0- 11,840 -0- -0-
---------------------------------------------------------------------------------------------
Jennifer Ericson Series I-125
-0- 10,000 -0- Series L-74
---------------------------------------------------------------------------------------------
William H. and Denise A. Van -0- 8,880 -0- -0-
Herpen
---------------------------------------------------------------------------------------------
John S. Allgyer -0- 5,920 -0- -0-
---------------------------------------------------------------------------------------------
Milton G. Brandolino -0- 5,920 -0- -0-
---------------------------------------------------------------------------------------------
Robert Brandolino -0- 5,920 -0- -0-
---------------------------------------------------------------------------------------------
Frederick J. Thomson -0- 5,920 -0- -0-
---------------------------------------------------------------------------------------------
Thomas Thomson -0- 5,920 -0- -0-
---------------------------------------------------------------------------------------------
Victoria Lee Coine-Arguello -0- 2,960 -0- -0-
---------------------------------------------------------------------------------------------
Roy Jenkins -0- 2,960 -0- -0-
---------------------------------------------------------------------------------------------
Scott Herbert Robinson -0- 2,960 -0- -0-
---------------------------------------------------------------------------------------------
Nestor H. and Mary Carmichael
Stewart -0- -0- -0- Series C-1, 000
---------------------------------------------------------------------------------------------
Barum Ashem Unlimited -0- -0- -0- Series G-2, 000
---------------------------------------------------------------------------------------------
TOTAL 3,880,596 2,122,812 205,872 4,929
---------------------------------------------------------------------------------------------
</TABLE>
<PAGE>
SCHEDULE 3.1
Jurisdictions in Which OWE is Qualified to Do Business
------------------------------------------------------
California
Officers and Directors of OWE
-----------------------------
Name Office
---- ------
Marshall L. Stewart President, Chief Executive Officer, Director
Daryl Meddings Vice President, Chief Financial Officer,
Secretary, Treasurer, Director
SCHEDULE 3.2
Shareholders of Ocean West Enterprises, Inc.
--------------------------------------------
Number of Shares
Name of OWE Held
---- -----------
Common Stock
------------
Daryl S. Meddings 12,867
Marshall L. Stewart 12,867
Agape Foundation Trust 4,266
Series C Preferred Stock
------------------------
Nestor H. and Mary Carmichael Stewart 1,000
Series D Preferred Stock
------------------------
Cheyenne Properties, Inc. 1,500
Series E Preferred Stock
------------------------
Ronald C. and Judy M. Meddings 800
Daryl Meddings 200
Marshall Stewart 200
Series F Preferred Stock
------------------------
Ronald C. and Judy M. Meddings 1,250
Series G Preferred Stock
------------------------
Barum Ashem Unlimited 2,000
<PAGE>
Series I Preferred Stock
------------------------
Kingsley and Nancy Cannon 300
Jennifer Ericson 250
Series K Preferred Stock
------------------------
Daryl S. Meddings 500
Marshall L. Stewart 500
Series L Preferred Stock
------------------------
Jennifer Ericson 74
Daryl S. Meddings 35
Marshall L. Stewart 20
Convertible Securities, Options,
--------------------------------
Warrants, Agreements Relating to Stock of OWE
---------------------------------------------
1. Monogenesis Corporation warrants to purchase 600 shares of Common
Stock.
SCHEDULE 3.12
Employee Benefit Plans
----------------------
1. Premium Reduction Option Cafeteria Plan adopted in 1993.
2. Ocean West Enterprises, Inc. 401(k) Profit Sharing Plan and Trust
adopted in 1997.
SCHEDULE 3.13
Intellectual Property
---------------------
1. Fannie Mae DESKTOP UNDERWRITER(R) - software designed to facilitate
the electronic underwriting of mortgage loan applications.
2. Fannie Mae GUIDE EXPRESS(R) by ADFINET - software containing the
electronic Fannie Mae Selling & Servicing Guides.
3. PowerPak - Origin Software Systems, Inc. processing software.
4. MAS90 - accounting software.
5. ADP PR software.
6. Fax Utility software.
<PAGE>
EXHIBIT 1.3
Form of Common Stock Purchase Warrants
--------------------------------------
See exhibit to Registration Statement.
EXHIBIT 3.5
Certificate Relating to Financial Statements
--------------------------------------------
FINANCIAL STATEMENTS CERTIFICATE
--------------------------------
The undersigned, President of Ocean West Enterprises, Inc. (the
"Corporation"), certifies that:
1. The balance sheet of the Corporation as of _________________ and the
income statement of the Corporation for the period beginning on April 1, 2000
and ending on ________________ (collectively, the "Financial Statements"), all
as attached hereto and provided in connection with the Stock Purchase Agreement
and Plan of Reorganization among the Corporation, its shareholders and
Monogenesis Corporation dated _____________, 2000, are complete and present
fairly the financial position of the Corporation.
2. The undersigned is not aware of any matters which are not reflected on
such Financial Statements or which would make such Financial Statements
misleading in any manner.
Witness the signature of the undersigned as of this ____ day of
______________, 2000.
By: _____________________________
Title: _____________________________
